SGIOY
Price
$8.99
Change
+$0.26 (+2.98%)
Updated
Sep 5 closing price
Capitalization
15.28B
49 days until earnings call
TAK
Price
$15.40
Change
+$0.11 (+0.72%)
Updated
Sep 5 closing price
Capitalization
48.68B
52 days until earnings call
Interact to see
Advertisement

SGIOY vs TAK

Header iconSGIOY vs TAK Comparison
Open Charts SGIOY vs TAKBanner chart's image
Shionogi & Co
Price$8.99
Change+$0.26 (+2.98%)
Volume$84.38K
Capitalization15.28B
Takeda Pharmaceutical
Price$15.40
Change+$0.11 (+0.72%)
Volume$3.33M
Capitalization48.68B
SGIOY vs TAK Comparison Chart in %
Loading...
SGIOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SGIOY vs. TAK commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SGIOY is a StrongBuy and TAK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (SGIOY: $8.99 vs. TAK: $15.40)
Brand notoriety: SGIOY and TAK are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: SGIOY: 101% vs. TAK: 86%
Market capitalization -- SGIOY: $15.28B vs. TAK: $48.68B
SGIOY [@Pharmaceuticals: Generic] is valued at $15.28B. TAK’s [@Pharmaceuticals: Generic] market capitalization is $48.68B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SGIOY’s FA Score shows that 2 FA rating(s) are green whileTAK’s FA Score has 2 green FA rating(s).

  • SGIOY’s FA Score: 2 green, 3 red.
  • TAK’s FA Score: 2 green, 3 red.
According to our system of comparison, SGIOY is a better buy in the long-term than TAK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SGIOY’s TA Score shows that 5 TA indicator(s) are bullish while TAK’s TA Score has 7 bullish TA indicator(s).

  • SGIOY’s TA Score: 5 bullish, 4 bearish.
  • TAK’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, both SGIOY and TAK are a good buy in the short-term.

Price Growth

SGIOY (@Pharmaceuticals: Generic) experienced а +4.41% price change this week, while TAK (@Pharmaceuticals: Generic) price change was +2.74% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

SGIOY is expected to report earnings on Oct 27, 2025.

TAK is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TAK($48.7B) has a higher market cap than SGIOY($15.3B). TAK has higher P/E ratio than SGIOY: TAK (53.30) vs SGIOY (13.29). SGIOY YTD gains are higher at: 29.169 vs. TAK (16.314). TAK has higher annual earnings (EBITDA): 1.13T vs. SGIOY (206B). SGIOY has more cash in the bank: 576B vs. TAK (419B). SGIOY has less debt than TAK: SGIOY (11.7B) vs TAK (4.51T). TAK has higher revenues than SGIOY: TAK (4.48T) vs SGIOY (419B).
SGIOYTAKSGIOY / TAK
Capitalization15.3B48.7B31%
EBITDA206B1.13T18%
Gain YTD29.16916.314179%
P/E Ratio13.2953.3025%
Revenue419B4.48T9%
Total Cash576B419B137%
Total Debt11.7B4.51T0%
FUNDAMENTALS RATINGS
SGIOY vs TAK: Fundamental Ratings
SGIOY
TAK
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
6
Undervalued
PROFIT vs RISK RATING
1..100
9195
SMR RATING
1..100
289
PRICE GROWTH RATING
1..100
5053
P/E GROWTH RATING
1..100
4433
SEASONALITY SCORE
1..100
7565

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TAK's Valuation (6) in the Pharmaceuticals Major industry is in the same range as SGIOY (22) in the null industry. This means that TAK’s stock grew similarly to SGIOY’s over the last 12 months.

SGIOY's Profit vs Risk Rating (91) in the null industry is in the same range as TAK (95) in the Pharmaceuticals Major industry. This means that SGIOY’s stock grew similarly to TAK’s over the last 12 months.

SGIOY's SMR Rating (2) in the null industry is significantly better than the same rating for TAK (89) in the Pharmaceuticals Major industry. This means that SGIOY’s stock grew significantly faster than TAK’s over the last 12 months.

SGIOY's Price Growth Rating (50) in the null industry is in the same range as TAK (53) in the Pharmaceuticals Major industry. This means that SGIOY’s stock grew similarly to TAK’s over the last 12 months.

TAK's P/E Growth Rating (33) in the Pharmaceuticals Major industry is in the same range as SGIOY (44) in the null industry. This means that TAK’s stock grew similarly to SGIOY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SGIOYTAK
RSI
ODDS (%)
Bearish Trend 4 days ago
50%
Bearish Trend 4 days ago
57%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
63%
Bullish Trend 4 days ago
43%
Momentum
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 4 days ago
32%
MACD
ODDS (%)
Bearish Trend 4 days ago
54%
Bullish Trend 4 days ago
46%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
62%
Bullish Trend 4 days ago
40%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 4 days ago
36%
Advances
ODDS (%)
Bullish Trend 12 days ago
65%
Bullish Trend 4 days ago
42%
Declines
ODDS (%)
Bearish Trend 7 days ago
58%
Bearish Trend 13 days ago
45%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
63%
Bearish Trend 4 days ago
50%
Aroon
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
36%
View a ticker or compare two or three
Interact to see
Advertisement
SGIOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTCH38.170.78
+2.09%
Match Group
CDRO8.240.12
+1.48%
Codere Online Luxembourg SA
WVVIP3.220.01
+0.31%
Willamette Valley Vineyards
ATRC35.38-0.28
-0.79%
AtriCure
WWR0.72-0.05
-6.16%
Westwater Resources

SGIOY and

Correlation & Price change

A.I.dvisor tells us that SGIOY and ANIP have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SGIOY and ANIP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGIOY
1D Price
Change %
SGIOY100%
+2.98%
ANIP - SGIOY
22%
Poorly correlated
-0.68%
EOLS - SGIOY
21%
Poorly correlated
+2.00%
TAK - SGIOY
20%
Poorly correlated
+0.72%
TKPHF - SGIOY
9%
Poorly correlated
+11.86%
ROMJF - SGIOY
8%
Poorly correlated
-4.79%
More

TAK and

Correlation & Price change

A.I.dvisor indicates that over the last year, TAK has been loosely correlated with HLN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if TAK jumps, then HLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAK
1D Price
Change %
TAK100%
+0.72%
HLN - TAK
43%
Loosely correlated
-0.41%
ZTS - TAK
29%
Poorly correlated
+0.08%
EOLS - TAK
24%
Poorly correlated
+2.00%
RDY - TAK
24%
Poorly correlated
+1.34%
DVAX - TAK
23%
Poorly correlated
+0.80%
More